PRIMO 2018 has started!
Check back for info
on PRIMO 2019!

The Practical Recommendations in Immuno and Molecular Oncology Conference

Is a unique opportunity to receive CME credits while staying ahead of the latest advances in immuno and molecular oncology.

The Annual PRIMO Meeting is designed to summarize key developments in cancer care over the past 12 months, and features anticipated advances that you and your patients will likely see in the upcoming year.

Agenda

The 2018 agenda has been curated to meet the educational needs of all attendees with an emphasis on the follow key areas:

Practical considerations of applying biomarkers and targeted therapy

Integration of immunotherapy, with a focus on novel management approaches

Patient selection, as well as timing and sequencing of therapy

Dealing with important trends, such a big data and defining value in cancer care

Faculty

An elite faculty has been assembled for the 2018 Annual PRIMO Meeting by our Steering Committee, led by our Co-Chairs Dr. Brahmer, Dr. Rugo, and Dr. Vose

Co-Chairs

Julie Brahmer, MD

Professor of Oncology
Director, Thoracic Oncology Program
Interim Director, Johns Hopkins
Kimmel Cancer Center at Bayview
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins School of Medicine
Baltimore, MD

Hope S. Rugo, MD

Professor of Medicine
Director, Breast Oncology
and Clinical Trials Education
UCSF Helen Diller Family
Comprehensive Cancer Center
San Francisco, CA

Julie M. Vose, MD, MBA

Neumann M. and Mildred E.Harris Professor
Chief, Division of Oncology/Hematology
Professor of Medicine
University of Nebraska Medical Center
Omaha, NE

Exhibitors and Sponsors

The PRIMO Meeting offers a fantastic opportunity for industry to interact with leading multidisciplinary oncologists and stay up to date with the latest information regarding targeted and immunologic therapies.